Literature DB >> 28714423

Distinctive neuropsychological profiles differentiate patients with functional memory disorder from patients with amnestic-mild cognitive impairment.

Sarah J Wakefield1, Daniel J Blackburn1, Kirsty Harkness2, Aijaz Khan2, Markus Reuber1, Annalena Venneri1.   

Abstract

OBJECTIVES: Patients with functional memory disorder (FMD) report significant memory failures in everyday life. Differentiating these patients from those with memory difficulties due to early stage neurodegenerative conditions is clinically challenging. The current study explored whether distinctive neuropsychological profiles could be established, suitable to differentiate patients with FMD from healthy individuals and those experiencing amnestic mild cognitive impairment (a-MCI).
METHODS: Patients with a clinical diagnosis of FMD were compared with patients with a-MCI, and healthy matched controls on several tests assessing different cognitive functions. Patients with clinically established mood disorders were excluded. Patients with FMD and a-MCI were broadly comparable on the level of their subjective memory complaints as assessed by clinical interview.
RESULTS: The neuropsychological profile of the FMD patients, although they expressed subjective memory and attention concerns during their clinical interview was distinct from patients with a-MCI on tests of memory [semantic fluency, age of acquisition (AoA) analysis of semantic fluency, verbal and non-verbal memory]. FMD patients did not differ significantly from healthy controls, but their scores on the letter fluency and digit cancellation tasks were not significantly different from those of the a-MCI patients indicating a possible sub-threshold deficit on these tasks.
CONCLUSION: Whilst subjective complaints are common within the FMD population, no objective impairment could be detected, even on a sensitive battery of tasks designed to detect subtle deficits caused by an early neurodegenerative brain disease. This study indicates that FMD patients can be successfully differentiated from patients with neurodegenerative memory decline by characterising their neuropsychological profile.

Entities:  

Keywords:  Alzheimer’s disease; amnestic; memory; neuropsychological testing

Mesh:

Year:  2017        PMID: 28714423     DOI: 10.1017/neu.2017.21

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  5 in total

1.  A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review.

Authors:  Tiago Teodoro; Mark J Edwards; Jeremy D Isaacs
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-05-07       Impact factor: 10.154

2.  Functional Cognitive Disorder Presents High Frequency and Distinct Clinical Profile in Patients With Low Education.

Authors:  Wyllians Vendramini Borelli; Priscylla Nunes de Senna; Wagner Scheeren Brum; Artur Francisco Schumacher-Schuh; Eduardo R Zimmer; Márcia Lorena Fagundes Chaves; Raphael Machado Castilhos
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.702

3.  A Graph Theory Approach to Clarifying Aging and Disease Related Changes in Cognitive Networks.

Authors:  Laura M Wright; Matteo De Marco; Annalena Venneri
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.750

4.  Prediction of Cognitive Decline in Temporal Lobe Epilepsy and Mild Cognitive Impairment by EEG, MRI, and Neuropsychology.

Authors:  Yvonne Höller; Kevin H G Butz; Aljoscha C Thomschewski; Elisabeth V Schmid; Christoph D Hofer; Andreas Uhl; Arne C Bathke; Wolfgang Staffen; Raffaele Nardone; Fabian Schwimmbeck; Markus Leitinger; Giorgi Kuchukhidze; Marlene Derner; Jürgen Fell; Eugen Trinka
Journal:  Comput Intell Neurosci       Date:  2020-05-20

Review 5.  Functional cognitive disorder: dementia's blind spot.

Authors:  Harriet A Ball; Laura McWhirter; Clive Ballard; Rohan Bhome; Daniel J Blackburn; Mark J Edwards; Stephen M Fleming; Nick C Fox; Robert Howard; Jonathan Huntley; Jeremy D Isaacs; Andrew J Larner; Timothy R Nicholson; Catherine M Pennington; Norman Poole; Gary Price; Jason P Price; Markus Reuber; Craig Ritchie; Martin N Rossor; Jonathan M Schott; Tiago Teodoro; Annalena Venneri; Jon Stone; Alan J Carson
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.